BIO Asia 2014 Plenary Sessions

  • Recommend
  • Tweet
  • Print
  • Email

2015 plenary sessions to be announced in December. Please check back.

Welcome Remarks

Tuesday, April 8, 2014, 9:00am - 9:25am
Coriander Room, 2nd floor


The Rise of Asian IPOs

Tuesday, April 8, 2014, 9:30-10:25am
Coriander Room, 2nd floor

The surge of biotech IPOs has not been limited to the U.S., as Asian investors in both Japan and Taiwan have warmly greeted a new generation of biotechs. Three biotech CEOs, who collectively have raised more than $200 million in IPOs, will discuss how they navigated the road to the public markets, how the investor climate has changed, how the next-generation Asian biotechs are different than the first generation, and how they plan to create value for their shareholders and patients, including their strategies for partnering and globalizing.




The Market for Health Care Innovation in Asia

Wednesday, April 9, 2014, 9:00-9:55am
Coriander Room, 2nd floor

As health care systems evolve in major Asian markets (e.g., Japan, China, Korea, Taiwan) so does the way that national health care systems in these markets reimburse innovative products. Countries want to develop and promote innovation; but at the same time they face serious constraints in their ability to manage growing health care demands, and often react with cost-containment measures that impede access to newer innovative treatments. This panel explores the trends in major Asian markets, and the outlook in the coming years.




Fitting Partnerships into Global Strategy 

Wednesday, April 9, 2014, 12:00 - 12:55pm
Grand Ballroom West, 3rd floor

Globalization means therapeutic assets can be found anywhere, and targeted for markets almost anywhere. In this luncheon plenary, Asian dealmakers discuss how very different transactions over the past year reflect their overarching strategic decisions about sourcing assets for R&D and each company's priorities for market development.